Biogen International Gmbh v. Jayesh Shah

Trademark battles are often painted as black-and-white fights where the winner gets everything and the loser gets nothing. But real-world disputes rarely fit such neat narratives. When a court injunction threatens to lock away inventory that is slowly losing its value, the law must grapple with a harder question: how do you protect a brand without destroying perfectly legitimate commercial value? The Biogen International Gmbh dispute offers a fascinating window into this tension.

Biogen International Gmbh, the plaintiff, found itself in a trademark conflict with Jayesh Shah, the defendant, over the mark 'DYFIRA.' The dispute had escalated to the point where Biogen sought court intervention to protect its brand, and an interim injunction had already been granted in its favor. However, the defendant was sitting on existing stock of goods bearing the 'DYFIRA' mark, stock that was subject to the injunction and could not be freely sold. Multiple applications were filed by both sides, each seeking to advance their respective positions in the ongoing conflict.

On one side stood Biogen, arguing for the strict enforcement of the interim injunction to prevent any further circulation of goods under the disputed mark. On the other side, Jayesh Shah faced a commercial reality: the existing stock of 'DYFIRA' was not infinite, and inventory left unsold would inevitably deteriorate in value or become unsellable altogether. The defendant sought relief that would allow him to monetize his existing legitimate stock without violating the court's protective order. The legal friction was clear: how could the court honor the injunction's intent while preventing the outright waste of existing inventory?

The court disposed of the various applications pending before it and confirmed the existing interim injunction, preserving Biogen's trademark protection. However, the court recognized the commercial reality facing the defendant and crafted a carefully balanced solution. Jayesh Shah was permitted to sell his existing stock of 'DYFIRA,' but only under specific conditions designed to safeguard Biogen's interests. Critically, the defendant was required to furnish a bank guarantee of Rs. 30 lacs to secure any potential damages that might arise from the sale. This order reflected the court's effort to honor the injunction's protective purpose while preventing the unnecessary destruction of commercial value tied up in existing inventory.

For founders and IP professionals, this case offers a powerful lesson in the practical realities of trademark enforcement. Winning an injunction is not the same as winning total victory, and courts will often look for ways to balance strict IP protection with legitimate commercial interests. If you are defending against an injunction, consider proactively proposing structured solutions, such as offering security or bank guarantees, that allow you to liquidate existing stock responsibly. If you are the brand owner seeking enforcement, anticipate that courts may permit limited, supervised sales of existing inventory, and build your litigation strategy around securing adequate financial guarantees rather than expecting a complete freeze on all related commerce.